is oral semaglutide fda approved for weight loss Approves FDA Approves First ORAL GLP-1

Storage: Store in a place protected from light and at temperatures not exceeding 25 C

Semaglutide triggers appetite suppression by activating GLP-1 receptors in your brain and guta process that often comes with temporary side effects like nausea, vomiting, and stomach discomfort

In rare cases, semaglutide can cause serious side effects that require medical attention, including: Pancreatitis (inflammation of the pancreas) Diabetic retinopathy (vision loss or damage) Severe hypoglycemia (low blood sugar) Increased heart rate Kidney problems Gallbladder problems An allergic reaction Depression or suicidal thoughts If you start to notice signs of any of the aboveincluding difficulty breathing or swallowing, severe rash or itching, feeling faint, changes in your vision, or severe stomach painstop taking semaglutide and contact a healthcare provider immediately

mean BMI, 38.5 kg/m 2 ) with overweight or obesity treated with semaglutide for 3 months or longer from January 2021 to March 2023